Efficacy of anti-IL-1 treatment in familial Mediterranean fever: a systematic review of the literature

van der Hilst JCH, Moutschen M, Breitscheidel L, et al.

Biologics · 2016

Grade Bsystematic review
PubMed ↗

Key Findings

  • ●Complete response in 76.5% on anakinra, 67.5% on canakinumab
  • ●5-10% colchicine resistant, 5-10% intolerant

Referenced in (1 disease)

Familial Mediterranean Fever
ID: pmid-27110096PMID: 27110096